Revolutionizing Insulin Production

This chapter explores the journey from animal-derived insulin to revolutionary synthetic alternatives, focusing on tandem kidney and pancreas transplants for diabetic patients. It highlights key advancements in genetic engineering during the 1980s, including the cloning of the human insulin gene into bacteria like E. coli. The discussion emphasizes both the scientific and ethical considerations that shaped modern insulin production and the intricate processes involved in extracting this vital hormone.